Events

 

Upcoming Events

 

August 15 - 18, 2017, Washington, D.C.

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, will speak at the Next Generation Diagnostics Summit 2017.

Link: http://www.nextgenerationdx.com/

 

September 8-12, 2017, Madrid, Spain

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, will attend the ESMO 2017 Congress.

Link: http://www.esmo.org/Conferences/ESMO-2017-Congress

 

September 11-14, 2017, Edinburgh, Scotland

Christoph Sachsenmaier, PhD, VP Strategic Business Development, Epiontis, will attend the 18th Meeting of the European Society for Immunodeficiencies (ESID 2017).

Link: http://esid2017.kenes.com/

 

October 19 - 20, 2017, Boston, MA

Novel Cancer Therapeutics Summit

Link: https://www.gtcbio.com/conferences/cancer-therapeutics-summit-overview?alias=cancer-therapeutics-summit

 

Previous Events

 

June 13 - 14, 2017, Boston, MA

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, spoke at the World Preclinical Congress "Cancer Immunotherapy and Combinations".

Link: http://www.worldpreclinicalcongress.com/Cancer-Immunotherapy-Combinations/

 

June 2 - 6, 2017, Chicago, Il

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, attended the 2017 ASCO Annual Meeting.

Link: http://am.asco.org

 

 May 12 - 16, 2017, Washington, D.C.

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, attended Immunology 2017 AAI Annual Meeting.

Link: http://www.immunology2017.org/

 

April 12 - 13, 2017, Lisbon, Portugal

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, spoke at the Biomarkers for Immunotherapy Conference as part of the Molecular Diagnostics Europe.

Link: http://www.moleculardxeurope.com/Immunotherapy-Biomarkers/

 

March 20 - 22, 2017, San Diego, CA

Thomas Kleen, PhD, Exec. VP Immune Monitoring at Epiontis, spoke at the Biomarker Summit 2017
by GTCbio.

Link: https://www.gtcbio.com/conferences/biomarkers-summit-agenda

 

February 6 - 7, 2017, San Diego, CA

Ulrich Hoffmüller, PhD, MBA, CBO and Founder of Epiontis, spoke at the ImmunoTX Summit
by GTCbio.

Link: https://www.gtcbio.com/conferences/immunotx-summit-agenda

 

November 8 - 9, 2016, San Fransisco, CA

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, spoke at the 5th Cancer Epigenetics Conference by GTCbio.

Link: https://www.gtcbio.com/conferences/cancer-epigenetics-agenda

 

November 1 - 2, 2016, Boston, MA

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, spoke at the Cancer Immunotherapy Conference 2016 by GTCbio.

Link: http://selectbiosciences.com/conferences/index.aspx?conf=CIBB2016

 

October 5 - 7, 2016, Berlin, Germany

Ulrich Hoffmüller, PhD, MBA, CBO and Founder of Epiontis, spoke at the Biomarker Summit Europe 2016 by GTCbio.

Link: https://www.gtcbio.com/conferences/biomarker-summit-europe-overview

 

June 3 - 7, 2016, Chicago, Il

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, attended the 2016 ASCO Annual Meeting.

Link: http://www.am.asco.org

 

April 5 - 6, 2016, Boston, MA

Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, spoke at the Phacilitates Oncology Leaders Forum 2016

Link: http://www.bostonleaders.com

 

March 21 - 23, 2016, San Diego, CA

Ulrich Hoffmüller, PhD, MBA, CBO and Founder of Epiontis, spoke at the Biomarker Summit 2016 by GTCbio.

Link: https://www.gtcbio.com/conferences/biomarkers-summit-overview

 

January 25 - 26, 2016, San Diego, CA

Ulrich Hoffmüller, PhD, MBA, CBO and Founder of Epiontis, spoke at the 8th Immunotherapeutics and Immunomonitoring Conference by GTCbio.

Link: https://www.gtcbio.com/conferences/immunotherapeutics-immunomonitoring-overview

 

 

  1. Privacy Statement: Your phone number or email address will be exclusively used to contact you and will not be given to any third party.